147 related articles for article (PubMed ID: 7189674)
1. Modulation of dopamine receptor sensitivity by estrogen.
Gordon JH; Borison RL; Diamond BI
Biol Psychiatry; 1980 Jun; 15(3):389-96. PubMed ID: 7189674
[TBL] [Abstract][Full Text] [Related]
2. Estrogen in experimental tardive dyskinesia.
Gordon JH; Borison RL; Diamond BI
Neurology; 1980 May; 30(5):551-4. PubMed ID: 7189262
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
Gordon JH; Diamond BI
Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
[TBL] [Abstract][Full Text] [Related]
4. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
De Veaugh-Geiss J; Devanand DP; Carey RJ
Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
[TBL] [Abstract][Full Text] [Related]
5. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
Minematsu N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
[TBL] [Abstract][Full Text] [Related]
6. Modulation of apomorphine-induced stereotypy by estrogen: time course and dose response.
Gordon JH
Brain Res Bull; 1980; 5(6):679-82. PubMed ID: 7193504
[TBL] [Abstract][Full Text] [Related]
7. d-Amphetamine-induced anorexia and motor behavior after chronic treatment in rats: relationship with changes in the number of catecholamine receptor sites in the brain.
Bendotti C; Borsini F; Cotecchia S; De Blasi A; Mennini T; Samanin R
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):36-49. PubMed ID: 6962686
[TBL] [Abstract][Full Text] [Related]
8. Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
Timar J; Knoll B; Knoll J
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):255-66. PubMed ID: 3103558
[TBL] [Abstract][Full Text] [Related]
9. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
Overstreet DH; Smee ML; Woolston ME
Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
[No Abstract] [Full Text] [Related]
10. Effects of dextromethorphan on dopamine dependent behaviours in rats.
Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
[TBL] [Abstract][Full Text] [Related]
11. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
[TBL] [Abstract][Full Text] [Related]
12. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
Dougherty GG; Ellinwood EH
Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
[TBL] [Abstract][Full Text] [Related]
14. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
Haleem DJ; Samad N; Haleem MA
Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
[TBL] [Abstract][Full Text] [Related]
15. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
16. Effects of ovariectomy, castration, and chronic lithium chloride treatment on stereotyped behavior in rats.
Verimer T; Arnerić SP; Long JP; Walsh BJ; Abou Zeit-Har MS
Psychopharmacology (Berl); 1981; 75(3):273-6. PubMed ID: 6275446
[TBL] [Abstract][Full Text] [Related]
17. Induction and reversal of dopamine dyskinesia in rat, cat, and monkey.
Lloyd KG; Willigens MT; Goldstein M
Psychopharmacology Suppl; 1985; 2():200-10. PubMed ID: 2987905
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
[TBL] [Abstract][Full Text] [Related]
19. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
[TBL] [Abstract][Full Text] [Related]
20. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
Pittman KJ; Jakubovic A; Fibiger HC
Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
